Study Finds Diabetes Medication Reduces Risk Of Death And Heart Disease In People With Arthritis August 12, 2024 (Vancouver) A study conducted by Arthritis Research Canada has revealed that certain diabetes medications, specifically glucagon-like peptide-1 receptor agonists (GLP-1-RAs) like semaglutide (Ozempic), reduced the risk of death and heart attacks in people with immune-mediated inflammatory diseases (IMIDs), such as rheumatoid arthritis, psoriasis, and lupus, who also have type 2 diabetes
Hypoglycemia : This is particularly a concern for those who are also taking other diabetes medications that can lower blood sugar
How knownwell Helps Patients Navigate Coverage Barriers At knownwell, we understand that prior authorizations can be one of the most frustrating parts of the patient and provider experience
Injectable vs oral BPC-157: Which to choose Your administration method depends on what you're treating
For best results, we recommend storing your pen in the fridge at 2C8C until you are ready to use it
However, the optimal dosage for weight loss is yet to be determined as the medication is still under clinical trials for weight management